These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2498049)

  • 21. [Clinical significance of bone scintigraphy for early detection of bone metastasis from breast cancer].
    Wada T; Hohjoh T; Matunami N; Yamato M; Kadota K; Morikawa E; Hara S; Matsuda T; Yasutomi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):781-5. PubMed ID: 2778373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
    Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
    J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
    Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
    Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy.
    Perez DJ; Powles TJ; Milan J; Gazet JC; Ford HT; McCready VR; MacDonald JS; Coombes RC
    Lancet; 1983 Sep; 2(8350):613-6. PubMed ID: 6136757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy].
    Suto Y; Tanigawa N; Iwamiya T; Kato T; Endo K; Shabana M; Ohta Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):953-9. PubMed ID: 8396760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer.
    Nicolini A; Carpi A; Ferrari P; Anselmi L; Spinelli C; Conte M; Miccoli P
    Br J Cancer; 2000 Dec; 83(11):1412-7. PubMed ID: 11076646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the accuracy of bone scintigraphy in breast tumors].
    Pupi A; Castagnoli A; Ciatto S; Meldolesi U
    Radiol Med; 1980 Nov; 66(11):842-4. PubMed ID: 6261307
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
    Lind P; Smola MG; Lechner P; Ratschek M; Klima G; Költringer P; Steindorfer P; Eber O
    Int J Cancer; 1991 Apr; 47(6):865-9. PubMed ID: 2010229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone imaging in the detection of skeletal metastasis].
    Shi QX
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):196-8. PubMed ID: 2612332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the chemical and biological properties of the skeletal imaging agent 99mTc-methylene diphosphonate.
    Vanlić-Razumenić N; Djokić D; Paunković N; Gorkić D
    Nuklearmedizin; 1982 Aug; 21(4):150-6. PubMed ID: 6216460
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of bone metastases in patients with breast cancer.
    Coombes RC; Dearnaley DP; Buckman R; Jones JM; Ormerod MG; Sloane JP; Powles TJ; Gazet JC; Ford HT; Neville AM
    Invasion Metastasis; 1982; 2(3):177-84. PubMed ID: 6234254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation of the results of gammagraphic study of the skeleton with the level of carcinoembryonic antigen and tissue polypeptide antigen in breast cancer].
    Makaiová I; Kausitz J; Hupka S; Michalíková B; Vivodová M; Simko S; Urbanová M; Bohunický L
    Cesk Radiol; 1986 May; 40(3):157-61. PubMed ID: 3719846
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors.
    Sasaki M; Ichiya Y; Kuwabara Y; Otsuka M; Fukumura T; Kawai Y; Koga H; Masuda K
    J Nucl Med; 1993 Feb; 34(2):288-90. PubMed ID: 8429349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of 3-phase skeletal scintigraphy in the diagnosis of bone metastases].
    Rieden K; Adolph J; Georgi P; zum Winkel K
    Rofo; 1987 Aug; 147(2):138-42. PubMed ID: 2819965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer.
    Findeisen R; Albrecht S; Richter B; Deutschmann K; Distler W
    Clin Chem Lab Med; 1998 Nov; 36(11):841-6. PubMed ID: 9877089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative roles of bone scintigraphy and positron emission tomography in assessing the treatment response of bone metastases.
    García JR; Simó M; Soler M; Pérez G; López S; Lomeña F
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1243-4. PubMed ID: 16133396
    [No Abstract]   [Full Text] [Related]  

  • 38. [The problem of false positives in bone scintigraphy in patients with breast neoplasms. A follow-up at 10 years].
    Campostrini F; Di Marco A; Micciolo R; Grandinetti A; Griso C; Palazzi M; Zamboni M
    Radiol Med; 1990 May; 79(5):539-43. PubMed ID: 2113699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer.
    Pecherstorfer M; Schilling T; Janisch S; Woloszczuk W; Baumgartner G; Ziegler R; Ogris E
    J Nucl Med; 1993 Jul; 34(7):1039-44. PubMed ID: 8315476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of nuclear medicine in the diagnosis of cancer of unknown origin.
    Demir H; Berk F; Raderer M; Plowman PN; Lassen U; Daugaard G; Clausen M; Bohuslavizki KH; Peters M; Harmer C; Malamitsi J; Aktolun C
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):164-73. PubMed ID: 15243411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.